Skip to content
2000
image of Evaluation of Carbamazepine and Gabapentin’s Safety and Efficacy in Trigeminal Neuralgia Treatment: A Systematic Review and Meta-Analysis

Abstract

Aim

This study aimed to assess the safety and effectiveness of carbamazepine in treating trigeminal neuralgia in contrast to gabapentin. Hence, a systematic review and meta-analysis of randomised controlled trials had been carried out.

Methods

The relevant studies were searched in PubMed and filtered according to the inclusion and exclusion criteria. Independently, two reviewers chose the studies, evaluated the quality of the investigations, and retrieved the data. RevMan was used for analysis when the data were collected and entered into the data extraction sheet. In addition to heterogeneity, the overall estimate measures were computed as mean differences with a 95% confidence interval for continuous data and relative risk for dichotomous data. To investigate the impact of outliers on the result, a sensitivity analysis was performed. A funnel plot was used to qualitatively evaluate the publishing bias. A total of 1,650 participants from 19 randomised controlled trials were evaluated.

Results

The meta-analysis revealed that the group receiving gabapentin therapy had a similar overall effective rate to the group receiving carbamazepine therapy (OR = 1.94, 95% CI 1.46, 2.57, 0.32). Additionally, our meta-analysis revealed that the group receiving gabapentin therapy witnessed a significantly lower risk of adverse reactions than the group receiving carbamazepine therapy (OR= 0.29, 95% CI 0.22, 0.387, 0.00001).

Conclusion

In summary, the current trials comparing carbamazepine and gabapentin have had inadequate methodological quality. It is not possible to conclude that gabapentin is more effective than carbamazepine in terms of adverse effects based on the evidence that is currently available.

Loading

Article metrics loading...

/content/journals/cchts/10.2174/0113862073353707250204061916
2025-02-24
2025-05-09
Loading full text...

Full text loading...

References

  1. Jeyaraj P. Efficiency and efficacy of real-time fluoroscopic image-guided percutaneous gasserian glycerol rhizotomy (PGGR), for intractable cases of trigeminal neuralgia. J. Maxillofac. Oral Surg. 2022 21 4 1053 1064 10.1007/s12663‑021‑01682‑2 36896085
    [Google Scholar]
  2. Larsen A Piepgras D Chyatte D Rizzolo D. Trigeminal neuralgia: Diagnosis and medical and surgical management: Trigeminal neuralgia is an exceedingly painful condition that leaves patients desperate for symptomatic relief. J. Am. Acad. Phys. 2011 24 7 20 25
    [Google Scholar]
  3. Nurmikko T.J. Eldridge P.R. Trigeminal neuralgia—pathophysiology, diagnosis and current treatment. Br. J. Anaesth. 2001 87 1 117 132 10.1093/bja/87.1.117 11460800
    [Google Scholar]
  4. Obermann M. Treatment options in trigeminal neuralgia. Ther. Adv. Neurol. Disord. 2010 3 2 107 115 10.1177/1756285609359317 21179603
    [Google Scholar]
  5. Maarbjerg S. Stefano D.G. Bendtsen L. Cruccu G. Trigeminal neuralgia – diagnosis and treatment. Cephalalgia 2017 37 7 648 657 10.1177/0333102416687280 28076964
    [Google Scholar]
  6. Wiffen P.J. Derry S. Bell R.F. Rice A.S.C. Tölle T.R. Phillips T. Moore R.A. Gabapentin for chronic neuropathic pain in adults. Cochrane Libr. 2017 2020 2 CD007938 10.1002/14651858.CD007938.pub4 28597471
    [Google Scholar]
  7. Gambeta E. Chichorro J.G. Zamponi G.W. Trigeminal neuralgia: An overview from pathophysiology to pharmacological treatments. Mol. Pain 2020 16 1744806920901890 10.1177/1744806920901890 31908187
    [Google Scholar]
  8. Obermann M. Recent advances in understanding/managing trigeminal neuralgia. F1000Res. 2019 8 F1000 Faculty Rev 505
    [Google Scholar]
  9. Burns L.M. Kinge E. Opdal S.M. Johannessen S.I. Landmark J.C. Therapeutic drug monitoring of gabapentin in various indications. Acta Neurol. Scand. 2019 139 5 446 454 10.1111/ane.13075 30710348
    [Google Scholar]
  10. Stefano D.G. Pietro D.G. Truini A. Cruccu G. Stefano D.G. Considerations when using gabapentinoids to treat trigeminal neuralgia: A review. Neuropsychiatr. Dis. Treat. 2023 19 2007 2012 10.2147/NDT.S407543 37745191
    [Google Scholar]
  11. Kumar A. Meta-analysis in clinical research: Principles and procedures. Singapore Springer 2023 10.1007/978‑981‑99‑2370‑0
    [Google Scholar]
  12. Elm E. Altman D.G. Egger M. Pocock S.J. Gøtzsche P.C. Vandenbroucke J.P. STROBE Initiative Strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. BMJ 2007 335 7624 806 808 10.1136/bmj.39335.541782.AD 17947786
    [Google Scholar]
  13. Oremus M. Oremus C. Hall G.B.C. McKinnon M.C. Inter-rater and test–retest reliability of quality assessments by novice student raters using the Jadad and Newcastle–Ottawa Scales. BMJ Open 2012 2 4 e001368 10.1136/bmjopen‑2012‑001368 22855629
    [Google Scholar]
  14. Agarwal R. Kumari S. Comparison of carbamazepine and gabapentin in management of trigeminal neuralgia- A clinical study. J. Adv. Med. Dent. Sci. Res. 2020 8 11 38 41
    [Google Scholar]
  15. Chen J. Study the feasibility and safety of gabapentin in the treatment of primary trigeminal neuralgia. Contemp. Med. 2018 24 142 143
    [Google Scholar]
  16. Zhu D.P. Zhang Y.N. Xu P.R. Randomized control trial of gabapentin and carbamazepine in the treatment of primary trigeminal neuralgia. West China Med. J. 2008 23 790 792
    [Google Scholar]
  17. Wang Y. Feasibility and safety of gabapentin in the treatment of primary trigeminal neuralgia. Rural Health China. 2014 54 36 37
    [Google Scholar]
  18. Yang Y.Q. Comparison of application value between gabapentin and carbamazepine in the treatment of primary trigeminal neuralgia. J. Aerospace Med. 2016 27 749 751
    [Google Scholar]
  19. Zhou J.W. Clinical efficacy and side effects of gabapentin and carbamazepine in the treatment of primary trigeminal neuralgia. Chin J Prac Nerv Dis. 2015 22 127 128
    [Google Scholar]
  20. Li G.S. Comparison of gabapentin and carbamazepine in the treatment of primary trigeminal neuralgia. J. China Pres. Drug. 2016 9 69 70
    [Google Scholar]
  21. Wang Y. Comparative analysis of gabapentin and carbamazepine in the treatment of primary trigeminal neuralgia. Modern Med. Health Res. 2019 3 23 24
    [Google Scholar]
  22. Fan Z.B. Chen X.P. Zhou X.P. Comparative analysis of gabapentin and carbamazepine in the treatment of primary trigeminal neuralgia. Jilin Med. 2016 37 103 104
    [Google Scholar]
  23. Zhao W.X. Comparative analysis of gabapentin and carbamazepine in the treatment of primary trigeminal neuralgia. Cardiovas Dis. J. Int. Trad. Chin. West Med. 2017 5 80
    [Google Scholar]
  24. Liu L.Q. Clinical efficacy and side effects of gabapentin and carbamazepine in the treatment of primary trigeminal neuralgia. Northern Pharm. 2020 17 162 163
    [Google Scholar]
  25. Zhang T. Xiao Q. Comparison of gabapentin and carbamazepine in the treatment of primary trigeminal neuralgia. Contemp. Med. Treatise. 2019 17 113 114
    [Google Scholar]
  26. Wang X.L. A comparative study of gabapentin and carbamazepine in the treatment of primary trigeminal neuralgia. Heilong. Trad. Chin. Med. 2019 48 178 179
    [Google Scholar]
  27. Huang Q.W. Sun G.Y. Cheng J.X. A. comparative study of gabapentin and carbamazepine in the treatment of primary trigeminal neuralgia. Chin. J. Prac. Nerv. Dis. 2012 15 33 35
    [Google Scholar]
  28. Zhou L. A comparative study of gabapentin and carbamazepine in the treatment of primary trigeminal neuralgia. Chin. J. Prac. Nerv. Dis. 2014 17 59 61
    [Google Scholar]
  29. San Y.Z. Zhao W.F. Cui K.G. Zhang L.K. Clinical study of gabapentin in treating trigeminal neuralgia. J. Clin. Med. 2016 3 6081 6084
    [Google Scholar]
  30. Gu W.X. Chen H. Ye X.R. Zhu J. Chen X.H. Comparative study of gabapentin in the treatment of primary trigeminal neuralgia. Mod Diagn Treat. 2010 21 8 10
    [Google Scholar]
  31. Zhou J. Yao S. Wu Y.H. Comparison of efficacy and safety between carbamazepine and gabapentin in the treatment of trigeminal neuralgia. J. Shenyang Med. College. 2017 19 224 225
    [Google Scholar]
  32. Liu P. Effect of carbamazepine and gabapentin on trigeminal neuralgia. China Hygiene Stand. Manage. 2020 11 94 96
    [Google Scholar]
  33. Jani R.H. Hughes M.A. Gold M.S. Branstetter B.F. Ligus Z.E. Sekula R.F. Jr Trigeminal nerve compression without trigeminal neuralgia: Intraoperative vs imaging evidence. Neurosurgery 2019 84 1 60 65 10.1093/neuros/nyx636 29425330
    [Google Scholar]
  34. Yao Y. Chang B. Li S. Relationship of inflammation with trigeminal neuralgia. J. Craniofac. Surg. 2020 31 2 e110 e113 10.1097/SCS.0000000000005879 31609955
    [Google Scholar]
  35. Ostertag C. Friedman T.N. Keough M.B. Kerr B.J. Sankar T. Heightened presence of inflammatory mediators in the cerebrospinal fluid of patients with trigeminal neuralgia. Pain Rep. 2023 8 6 e1117 10.1097/PR9.0000000000001117 38125050
    [Google Scholar]
  36. Kumari A. Silakari O. Singh R. K. Recent advances in colony stimulating factor-1 receptor/c-FMS as an emerging target for various therapeutic implications. Biomed. Pharmacother. 2018 103 662 679
    [Google Scholar]
  37. Liu M.X. Zhong J. Xia L. Dou N.N. Li S.T. A correlative analysis between inflammatory cytokines and trigeminal neuralgia or hemifacial spasm. Neurol. Res. 2019 41 4 335 340 10.1080/01616412.2018.1564188 30612530
    [Google Scholar]
  38. Singh R.K. Devi S. Prasad D.N. Synthesis, physicochemical and biological evaluation of 2-amino-5-chlorobenzophenone derivatives as potent skeletal muscle relaxants. Arab. J. Chem. 2015 8 3 307 312 10.1016/j.arabjc.2011.11.013
    [Google Scholar]
  39. Singh R.K. Prasad D.N. Bhardwaj T.R. Synthesis, physicochemical and kinetic studies of redox derivative of bis(2-chloroethylamine) as alkylating cytotoxic agent for brain delivery. Arab. J. Chem. 2015 8 3 380 387 10.1016/j.arabjc.2012.11.005
    [Google Scholar]
  40. Zhou M. Chen N. He L. Yang M. Zhu C. Wu F. Oxcarbazepine for neuropathic pain. Cochrane Database Syst. Rev. 2017 12 12 CD007963 29199767
    [Google Scholar]
  41. Naderi Y. Rad M. Sadatmoosavi A. Khaleghi E. Khorrami Z. Chamani G. Shabani M. Compared to oxcarbazepine and carbamazepine, botulinum toxin type A is a useful therapeutic option for trigeminal neuralgia symptoms: A systematic review. Clin. Exp. Dent. Res. 2024 10 2 e882 10.1002/cre2.882 38558383
    [Google Scholar]
  42. Kaur B. Dhir P. Evaluation of the efficacy of carbamazepine and gabapentin in the management of trigeminal neuralgia: A clinical study. J. Indian Acad. Oral Med. Radiol. 2018 30 3 253 256 10.4103/jiaomr.jiaomr_75_18
    [Google Scholar]
  43. Davari M. Amani B. Amani B. Khanijahani A. Akbarzadeh A. Shabestan R. Pregabalin and gabapentin in neuropathic pain management after spinal cord injury: A systematic review and meta-analysis. Korean J. Pain 2020 33 1 3 12 10.3344/kjp.2020.33.1.3 31888312
    [Google Scholar]
  44. Rissardo J.P. Medeiros Araujo de Matos U. Caprara F.A.L. Gabapentin-associated movement disorders: A literature review. Medicines 2023 10 9 52 10.3390/medicines10090052 37755242
    [Google Scholar]
  45. Zhao X. Ge S. The efficacy and safety of gabapentin vs. carbamazepine in patients with primary trigeminal neuralgia: A systematic review and meta-analysis. Front. Neurol. 2023 14 1045640 10.3389/fneur.2023.1045640 37200780
    [Google Scholar]
/content/journals/cchts/10.2174/0113862073353707250204061916
Loading
/content/journals/cchts/10.2174/0113862073353707250204061916
Loading

Data & Media loading...

Supplements

PRISMA checklist is available as supplementary material on the publisher’s website along with the published article.

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test